A persistent ankle sore, especially with accompanying swelling, itching, and darkened skin, is likely a venous ulcer rather than a simple cut. 

The root issue is related to circulation, altering the approach to effective treatment. This outlines the causes, recognition, treatment, and healing factors of these ulcers.

What Causes Venous Ulcers?

The root mechanism is chronic venous insufficiency. Veins in the legs rely on one-way valves to push blood back toward the heart. When those valves weaken or fail, blood pools in the lower leg. This creates sustained high pressure, known as venous hypertension, which damages small vessels and skin over time.

Major risk factors include varicose veins, a prior deep vein thrombosis (DVT), obesity, pregnancy, jobs that require prolonged standing, and family history of vein disease. Having a previous venous ulcer is itself a strong predictor that it can recur, which is why long-term management matters as much as healing the first wound.

Recognizing Venous Ulcer Symptoms

Early venous ulcer symptoms often show up before an open wound does. This includes ankle swelling that worsens through the day, a heavy or aching feeling in the legs, persistent itching, visible varicose veins, and brown or reddish skin discoloration around the lower calf.

The ulcer itself typically appears near the inner ankle. It is usually shallow with irregular borders and may weep clear or yellowish fluid. Warning signs of infection include increasing redness, warmth, foul odor, worsening pain, or fever. 

As a general rule, any lower-leg wound that stays open beyond 2 to 4 weeks deserves professional evaluation.

How Serious Is a Venous Ulcer?

There are real risks with untreated or poorly managed venous ulcers. Infection can spread into surrounding tissue (cellulitis), and repeat infections increase the chance of longer-term complications. The ulcers also cause chronic pain and reduced mobility, which affect sleep, daily activity, and mental health more than most people expect.

These ulcers are also chronic in nature, with a high recurrence rate when the underlying vein disease is not managed. This is not an immediate emergency in most cases, but it becomes more serious over time. The earlier you treat chronic venous ulcers and address the root cause, the better the long-term outcome.

Is a Venous Ulcer Curable?

Most venous ulcers can heal completely with proper treatment, so the visible wound is curable. However, the underlying venous insufficiency causing them usually persists. Without ongoing management for it, there is the risk of a new ulcer forming.

Healing time varies. Small, recent ulcers can close within weeks, whereas larger or long-standing ones may take months. Key factors that affect the timeline include ulcer size, how long it has been open, whether it is infected, and how consistently the patient uses compression and follows lifestyle changes.

Venous Ulcer Treatment and Supportive Therapy

Compression therapy is the foundation of standard venous ulcer treatment. Compression stockings or multi-layer bandages reduce venous pressure and help blood return to the heart. Skipping compression is the most common reason ulcers heal slowly or recur.

Local wound care handles the surface, involving gentle cleansing, debridement to remove dead tissue, and moisture-balanced dressings appropriate to the wound stage. Supportive therapy for venous ulcers covers the lifestyle side, including leg elevation, regular walking to activate the calf muscle pump, weight management, and smoking cessation. 

But if conservative treatment plateaus despite consistent care, vein procedures or advanced wound therapies may be considered next.

Vega’s Approach to Chronic Wound and Diabetic Wound Care

At Vega Dermatology & Wound Care Unit, our chronic wound program starts with comprehensive assessment. This includes circulation testing, wound staging, and identifying whether venous, arterial, or mixed factors are driving the wound.

For wounds that have plateaued despite standard care, our team may introduce a VEGF and PDGF growth factor strategy as regenerative support for suitable candidates. We use objective wound-area measurement and serial tracking so healing progress is documented. This is designed to complement standard compression and wound care, not replace it, and includes overlap with chronic wound healing protocols used for diabetic and mixed-etiology wounds.

Manage Venous Ulcers for the Long Term

Venous ulcers stem from underlying vein disease, not from a simple slow-healing cut. Most heal well with proper compression, wound care, and lifestyle changes. But since the vein disease usually stays, keeping the ulcers at bay involves proper long-term management and recurrence prevention.

At Vega Dermatology & Wound Care Unit, we combine structured wound assessment with growth factor support for wounds that haven’t responded to standard compression and dressing protocols. We track your progress over time and adjust the plan as your wound and circulation change.

It’s common to get small cuts, scrapes, and skin injuries, and most will mend themselves. Your body’s natural healing process involves clotting, cleaning, and rebuilding, so in one to two weeks, the wound will likely be forgotten.

The challenge lies in identifying when an injury is becoming a concern. While the signs might be faint, they could point to an underlying condition. This guide explains what to look for.

What A Healthy Healing Wound Looks Like

In the first day or two, a wound may look and feel slightly worse before it gets better. Signs of normal healing include:

• Mild redness along the wound edges, not spreading outward
• Slight warmth and swelling as your immune system responds
• Clear or light pink drainage in small amounts
• Pain that eases day by day, with swelling settling by day three or four
• New tissue forming under the scab, often pink, slightly bumpy, and slightly raised (granulation tissue)

Behind the scenes, wound healing moves through four overlapping phases:

• Hemostasis: When bleeding stops
• Inflammation: Immune cells clean the wound
• Proliferation: New tissue and blood vessels form
• Remodeling: The scar strengthens and matures

Most acute wounds finish that whole process within 4 to 6 weeks.

Signs of An Infected Wound 

Common signs of infection include:

• Redness that spreads outward from the wound edges rather than staying contained
• Swelling that worsens after the first few days instead of settling
• Warmth that feels hotter than the surrounding skin
• Yellow, green, or cloudy pus, especially with a foul odor
• Increasing pain or tenderness when it should be improving
• Delayed healing, where the wound stalls or looks the same day after day

Some symptoms are more serious. They may point to an underlying infection that has moved beyond the skin itself. Seek medical attention if you notice:

• Fever or chills 
• Red streaks extending from the wound toward the trunk of the body
• Swollen, tender lymph nodes near the wound
• Feeling generally unwell, fatigued, or lightheaded

How Wound Infections Develop 

Common causes include bacteria entering through broken skin, poor wound hygiene, dressings that go too long between changes, and foreign material left in the wound (such as dirt, splinters, or glass).

Certain conditions and habits may increase your risk of an infected wound:

• Diabetes impairs immune response and slow tissue repair
• Poor circulation in the lower legs and feet
• Weakened immune system from illness or medications
• Smoking reduces oxygen delivery to healing tissue
• Larger or deeper wounds where more tissue is exposed
• Wounds on the lower legs or feet face more mechanical stress

How To Care For A Wound At Home

• Wash your hands before touching the wound or changing the dressing
• Rinse the wound gently with clean running water; you don’t need hydrogen peroxide or iodine, which can irritate healthy tissue
• Keep it covered with an appropriate dressing to keep it clean and moist
• Change dressings as recommended, or sooner if they get wet, dirty, or saturated
• Watch for change daily; healing should trend better, not worse

What Not To Do 

• Don’t pick at scabs or peel dressings roughly. Both interrupt the tissue rebuilding underneath.
• Don’t over-clean with harsh antiseptics day after day. It slows healing.
• Don’t ignore worsening symptoms hoping they’ll settle. Early attention beats late intervention every time.
• Don’t leave foreign material in the wound. If you can’t remove it safely, get a professional assessment.

When To See A Doctor

See a healthcare professional if any of the following apply to you:

• Redness that continues to spread.
• Pus develops, especially yellow, green, or foul-smelling drainage.
• Pain becomes more severe.
• The wound isn’t improving after several days of proper care.
• You develop fever, chills, or red streaks.
• If you live with diabetes or poor circulation.
• The wound is deep, gaping, or from a bite or dirty object.

When A Wound Becomes Chronic

Chronic wounds are those that remain open for approximately 4 to 6 weeks, even with regular treatment. The wound becomes trapped in the inflammatory phase, experiencing recurrent infections and slow healing rather than progressing to closure.

Common reasons include:

• Persistent infection that keeps the wound inflamed.
• Poor blood supply, especially in the lower legs.
• Ongoing pressure or friction on the wound site.
• Underlying medical conditions like diabetes or venous disease.
• Long-term inflammation from unresolved causes.

Once a wound has stalled, general first-aid rarely closes it. It usually requires professional chronic wound care treatment that correctly identifies the factors that are delaying healing.

At Vega Dermatology & Wound Care Unit, every case starts with an assessment by our qualified physicians to identify what’s blocking healing, whether that’s circulation, infection, glycemic control, tissue quality, or a combination of them. 

Advanced care may include growth factor support strategies under medical supervision. We use targeted bio-signals like VEGF and PDGF, which are proteins your body naturally uses to grow new blood vessels and skin tissue, to help jumpstart healing in areas where circulation or repair has stalled. 

This is especially helpful for individuals with diabetic wounds, those needing surgical repair, or patients whose wounds aren’t healing with standard treatments. Schedule a consultation with our clinical team for a wound care assessment or treatment plan.

References:

• Wound Healing Phases. Retrieved November 7, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK470443/
• Physiology, Wound Healing. Retrieved November 7, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK535406/
• Wound Assessment. Retrieved November 7, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK482198/
• How wounds heal. Retrieved November 7, 2026, from https://medlineplus.gov/ency/patientinstructions/000741.htm

The right choice when comparing PRP vs FSE for hair loss depends on the stage of thinning, whether a transplant is planned, and what a scalp assessment reveals. PRP and FSE are two names that will appear in any research on non-surgical hair loss solutions. While both might help with thinning hair without surgery, they operate differently and are better for distinct scenarios.

What Is PRP Hair Treatment?

PRP, or platelet-rich plasma, is a non-surgical treatment that begins with a small blood sample drawn from the patient. That sample is spun in a centrifuge to concentrate the platelets, which carry growth factors that may support existing follicles when applied to thinning areas of the scalp. These growth factors support hair returning to a normal growth cycle by aiding thinner, weaker strands. Consequently, PRP is ideal for individuals experiencing early to moderate hair loss who still possess visible hair in the treated area. For areas that have been fully bald for an extended period, PRP is generally not considered, as the follicles may no longer be viable enough to respond.

How Long Does PRP Hair Treatment Last?

Most PRP protocols begin with an initial series of sessions spaced a few weeks apart, and visible changes usually start to appear from around three to six months after treatment begins. The results, however, are not permanent, so most patients need maintenance sessions every several months to hold the improvement. The duration and effectiveness of results can differ based on age, hair loss severity, and scalp condition, making physician-guided PRP most beneficial within a comprehensive treatment strategy. If a patient’s thinning affects more than just the hair follicles, another method might be beneficial.

What Is FSE for Hair Loss?

While PRP targets the follicle directly, Follicular Signaling Enhancement, or FSE, takes a different approach by focusing on the scalp environment around the follicle. It uses concentrated signaling molecules delivered into the area surrounding the follicles to address circulation, low-grade inflammation, and the biological signaling that determines whether a follicle stays dormant or restarts its growth cycle.

This environmental focus makes FSE particularly relevant for patients whose scalp shows signs of chronic inflammation or reduced blood flow alongside visible thinning. This can also be viewed in conjunction with hair transplantation to enhance graft results, as the scalp conditions affecting natural hair also impact the successful integration and survival of transplanted follicles. The main point for selecting the best treatment or determining if both are necessary is understanding the differences between this approach and PRP.

PRP vs FSE: The Key Differences

Although both treatments support thinning hair without surgery, they differ in several important ways:

• What they use: PRP is drawn from the patient’s own blood, while FSE uses signaling molecules delivered into the follicle environment.
• What they target: PRP stimulates existing follicles directly through platelet-derived growth factors, while FSE focuses on restoring the scalp environment around the follicle.
• How they fit into a plan: PRP works well as a booster in early to moderate thinning, while FSE suits patients wanting a longer-term regenerative approach or those planning a hair transplant.

The two often complement each other because they operate using different methods. Combining PRP and FSE under a doctor’s supervision could provide a more comprehensive solution for certain patients, especially when simultaneously stimulating follicles and improving the scalp’s condition is necessary.

PRP vs FSE for Hair Loss in Women

Female pattern hair loss tends to be more diffuse and often involves hormonal factors, which means the treatment plan usually needs to address more than the follicle alone. PRP may suit women with early to moderate thinning, persistent postpartum shedding, or those wanting to reduce reliance on daily medications, while FSE may suit women whose thinning comes with scalp symptoms such as itching or sensitivity, or where earlier approaches have not delivered the expected result. The choice between PRP vs FSE for hair loss in female patients often comes down to whether the primary issue is follicle weakness or broader scalp environment factors.

PRP vs FSE for Hair Loss in Men

Male pattern hair loss follows a different trajectory, usually presenting as a receding hairline or thinning at the crown driven mainly by genetic and hormonal factors. PRP may suit men in early to mid-stage thinning who still have miniaturized follicles in the pattern area and want to slow visible thinning before considering a transplant. FSE may suit men who are planning a transplant or who have already had one, since it works on the scalp environment where grafts settle and native hair needs ongoing support. Some men benefit from starting with PRP to assess how their scalp responds, then adding FSE if a transplant becomes part of the longer-term plan. When evaluating PRP vs FSE for hair loss in male patients, the deciding factor is often whether the goal is a short-term biological boost or a longer-term environmental foundation.

Which One Fits Your Situation?

Neither PRP nor FSE is universally better, and the right choice depends on the stage and pattern of hair loss, whether a transplant is planned, and what a proper assessment shows. PRP tends to lead when the goal is a straightforward biological boost for existing follicles, while FSE tends to lead when the scalp environment itself needs work or when a longer-term regenerative plan matters more than a short-term lift. For some patients, the answer is both, sequenced under physician guidance.

Vega Dermatology & Wound Care Unit provides hair follicle regeneration and hair follicle stem cell therapy in Thailand through a physician-led program where PRP and FSE are among the treatment options available.  Every plan starts with a detailed scalp assessment, so recommendations are based on what your hair actually needs rather than a one-size-fits-all protocol. To understand how PRP and FSE can best serve you, whether you’re new to them or considering them for the long haul, schedule a consultation with our clinical team. They’ll help you determine the right approach for your hair loss stage and next steps.

References:

• Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. Retrieved 14 July 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374694/ 
• Platelet-Rich Plasma Effectiveness in Treating Androgenetic Alopecia: A Comprehensive Evaluation. Retrieved 14 July 2026, from https://pmc.ncbi.nlm.nih.gov/articles/PMC11817460/

Several months into Ozempic, the weight is coming off and you feel good about it. Then one morning you notice clumps of hair in your brush and heavy shedding in the shower. It is jarring, and it makes sense to blame the drug. But the cause is rarely the medication attacking your follicles directly. 

However, clinical evidence suggests hair loss is not directly caused by Ozempic itself, but rather by rapid weight loss and the nutrient shifts that come with it. Here is what is actually happening to your body, and what you can do about it.

Can Ozempic Actually Cause Hair Loss?

Among the reported Ozempic side effects, hair loss has become one of the most discussed. Recent research has found that people taking semaglutide (the active ingredient in Ozempic) are diagnosed with hair loss at higher rates than people on some other weight-loss medications. Women show a notably higher diagnosed rate than men.

However, this is an observed association, not proof that Ozempic hair loss side effects come from direct follicle damage. The more likely mechanism is indirect: rapid weight loss puts the body under significant stress, and that stress reaches the hair cycle before it reaches anything else. This means that hair loss due to Ozempic is a weight-loss-driven effect instead of a direct drug effect, which needs different responses.

Why It Happens: The Telogen Effluvium Connection

Most Ozempic-related shedding falls under a pattern called telogen effluvium. This is a stress-induced shift in the hair growth cycle, not permanent follicle loss. When the body faces a major stressor (rapid weight loss, illness, surgery, childbirth), a larger-than-usual share of hairs move from the growth phase into the resting phase and then shed a few months later.

Rapid caloric restriction is a classic trigger. When calories drop sharply, the body diverts nutrients toward essential functions and away from things it treats as non-essential, including hair growth. What’s more, protein and key micronutrients (iron, zinc, vitamin D, B12) commonly run low during aggressive weight loss, and those gaps compound the effect. The shedding usually shows up 2 to 3 months after the trigger, not immediately.

What Ozempic Hair Loss Looks Like in Women

The typical presentation is diffuse thinning across the whole scalp rather than a specific bald patch. You might notice a widening part, thinner ponytail, more strands on the pillow, or clumps in the shower drain. Some women also notice texture changes, with hair feeling finer or flatter than usual.

This pattern is different from female pattern hair loss, which is more localized around the crown and part line and tends to progress gradually over years. The distinction is important, because telogen effluvium usually resolves once the trigger is addressed, whereas pattern hair loss needs a different treatment approach.

How to Stop Hair Loss From Ozempic

Talk to the doctor who prescribed the medication before making any changes. Ozempic is not a regular over-the-counter medication, so adjusting your dose or timeline is a medical decision.

From there, a few other things genuinely help:

• Slow the pace of weight loss to a more sustainable rate under medical guidance. 
• Aggressive weekly losses are the biggest single risk factor for stress-related shedding. 
• Prioritize protein intake and check for the common micronutrient gaps (iron, zinc, vitamin D, B12). 
• Consider bloodwork if the shedding is significant. 
• Maintain gentle scalp care.
• Avoid tight hairstyles, harsh chemical treatments, and heavy heat styling while your hair is actively recovering.

Why You Can’t Stop It Overnight

An important note is that the hair growth cycle runs on months, not days. Once a large batch of hairs has shifted into the resting phase, they will shed on their own schedule regardless of what you change today. Don’t buy into any product or protocol promising to reverse this within a week.

But what you can change overnight is appearance, using volumizing shampoo, gentler brushing, and having a fresh cut that hides thin spots. Actual biological recovery takes 3 to 6 months once triggers are addressed. Starting the right plan now shapes how much recovery you get, but it does not compress the timeline.

Vega’s Approach to Hair and Scalp Regeneration

At Vega Dermatology & Wound Care Unit, we treat the hair follicle as a biological unit affected by circulation, inflammation, and cellular signaling. This matters when the underlying trigger is systemic, like rapid weight loss.

Our clinic offers Follicular Signaling Enhancement (FSE), designed to support scalp microenvironment recovery for suitable candidates dealing with stress-related shedding. We use trichoscopy and objective tracking to monitor how your follicles respond over time. This is especially relevant if your shedding persists beyond the typical recovery window despite nutrition and lifestyle changes, or if you want structured hair loss therapy alongside your Ozempic plan.

Support Long-Term Hair Recovery

Hair loss can happen indirectly due to Ozempic, but this is usually a temporary stress response, not permanent damage. Addressing the triggers (pace of weight loss, protein, key micronutrients), giving the hair cycle 3 to 6 months to reset, and staying patient with the timeline can help restore your hair’s condition. If progress stalls or other causes are suspected, a professional consultation can help uncover what’s happening.

At Vega Dermatology & Wound Care Unit, we track recovery with trichoscopy and physician-led assessment so you can see whether your follicles are actually rebounding. Our team may combine medical stabilization, physician-assessed regenerative support such as Follicular Signaling Enhancement for suitable candidates, and continued nutrition guidance, adjusting the plan as your recovery progresses.

People worried about losing their hair attempt various methods to improve their condition. But will merely altering your diet be adequate? Should that be true, what nutrients are most successful against hair loss? While nutrients fuel hair growth, exceeding adequate levels seldom rectifies significant issues.

Do Vitamins Actually Help Hair Grow?

Hair follicles are metabolically active tissue. They rely on a steady supply of protein, iron, zinc, and several vitamins to sustain the growth (anagen) phase of the hair cycle. When a true deficiency is present, correcting it often reduces shedding and improves hair quality over several months. Providing more of something when levels are already sufficient yields minimal extra advantages and can sometimes be detrimental.

Supplements cannot override the underlying biology of pattern hair loss, hormonal shifts, autoimmune conditions, or scalp inflammation. These usually require targeted, physician-assessed treatment alongside good nutrition.

The Vitamins That Matter Most For Hair

For patients researching vitamins for hair growth and thickness, the nutrients most consistently linked to hair health include:

• Vitamin D: Supports normal follicle function. Low levels have been associated with certain types of hair loss. 
• Biotin (Vitamin B7): Involved in healthy hair structure, but supplementation primarily helps people with a true biotin deficiency, which is uncommon. Excess biotin can also interfere with laboratory tests (thyroid and cardiac markers), so mention supplementation to your physician before blood work.
• Iron: Iron deficiency is a common cause of excessive shedding, particularly in women. Serum ferritin gives a clearer picture than hemoglobin alone.
• Zinc: Supports normal cell growth and follicle function. Low levels may contribute to shedding.
• Vitamin B12 and folate: Involved in red blood cell production and healthy cell turnover, including at the follicle.
• Protein and omega-3 fatty acids: The building blocks and lipid support that affects healthier hair strands.
• Vitamin C: Supports iron absorption and antioxidant activity at the scalp.

We strongly recommend evaluating deficiencies through a comprehensive blood test. Always seek professional advice before beginning supplementation. 

Vitamins For Hair Growth In Food

Whole foods provide nutrients in synergistic combinations, along with minerals and phytonutrients. Once a deficiency is confirmed, increase the consumption of these foods.

Are Prenatal Vitamins Good For Hair Growth?

Many people believe prenatal vitamins thicken hair because pregnant women often experience denser hair. This is mostly caused by pregnancy hormones that may extend the growth phase of the hair cycle. 

Prenatal supplements are made for pregnancy needs, not general hair growth, even though they have extra iron and folate for hair health during deficiencies. 

Taking them outside of pregnancy without a clinical reason may provide excess iron or other nutrients you do not need. If you are researching the best prenatal vitamins for hair growth and you are not pregnant or planning pregnancy, seeking an evaluation with a medical professional for your hair loss may be safer.

When Vitamins Alone May Not Be Enough

Certain patterns point to hair loss that will not respond to supplements alone:

• Progressive thinning at the crown or temples.
• A receding hairline.
• Patchy loss.
• A family history of patterned hair loss.
• Shedding continues for more than three months despite good nutrition.
• Persistent scalp inflammation, itching, or visible redness.
• Sudden, heavy shedding after illness, stress, or a change in medication.

Early assessment can help protect the follicles that are still active before hair loss worsens.

Supporting Hair Growth With Regenerative Therapies

Once nutritional gaps have been addressed, care usually focuses on scalp health and follicle function directly. 

Regenerative options offered at Vega use secretome-based signaling (chemical messengers that communicate directly with cells) to help revitalize the scalp environment and encourage dormant follicles back into activity. Follicular Signaling Enhancement (FSE) is one such approach. It is an advanced hair follicle regeneration therapy that delivers signals to support the follicles you still have. Treatment response varies from person to person, and the most suitable plan depends on your specific cause and stage of hair loss.

A consultation with our skilled doctors will determine if nutrition, medication, or a hair and scalp regeneration plan is best for you. Experience our tailored hair therapy for hair loss that has supported individuals of all backgrounds in a discreet, private clinical setting. Book a consultation with our clinical team for a scalp assessment today.

References:

• Diet and Hair Loss: Effects of Nutrient Deficiency and Supplement Use. Retrieved June 10, 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315033/
• The Role of Vitamins and Minerals in Hair Loss: A Review. Retrieved June 10, 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380979/
• Iron Deficiency Anemia. Retrieved June 10, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK448065/
• Hair Loss. Retrieved June 10, 2026, from https://medlineplus.gov/hairloss.html

If this is happening right now

• Cool the burn under cool running water for 20 minutes. Start as soon as possible. Cooling still helps if begun within three hours of the injury.
• Do not use ice, iced water, toothpaste, fish sauce, butter, oil, or herbal pastes. Ice causes blood vessels to constrict, which can deepen the burn or cause a cold injury.
• Remove clothing and jewellery from the area unless it is stuck to the skin. Swelling comes quickly.
• Call emergency services (1669 in Thailand) or go to hospital immediately for large burns, burns to the face, hands, feet, genitals or joints, burns that go all the way around a limb, chemical or electrical burns, any burn in a child, or if smoke was inhaled.

This article is educational. It does not replace emergency care. Vega Dermatology & Wound Care Unit is an outpatient clinic and does not provide emergency burn treatment. We support smaller outpatient burns, post-hospital recovery, and treatment for burn scars.

Burn first aid, and why 20 minutes is the number

A burn is not a single event. Heat continues to transfer into tissue after the source is removed, and the injury can progress in depth over the following 48 hours. Prompt first aid limits how far that damage travels.

Cool running water at roughly 8 to 25 degrees Celsius for at least 20 minutes has been shown to reduce burn depth. If cooling is started within three hours of the injury, it reduces pain and swelling, slows cellular metabolism in oxygen-starved tissue, dampens the inflammatory response, and improves wound healing while reducing scarring.

A prospective cohort study drawing on the Burn Registry of Australia and New Zealand analysed patients treated between 2009 and 2012 and found that first aid cooling before arrival at a burn service was associated with reduced injury severity across measured outcomes.

Cool running water dissipates heat better than a cold compress. Ice and iced water should be avoided because vasoconstriction can deepen the burn or cause a cold injury.

After cooling:

• Cover loosely with cling film laid over the wound, not wrapped tightly around a limb, or with a clean non-fluffy cloth
• Keep the person warm overall, since prolonged cooling of a large burn can drop body temperature dangerously
• Do not burst blisters
• Take simple analgesia if there is no contraindication
• Seek medical review, even if it looks minor

When a burn needs hospital or specialist care

Not every burn can be managed at home or at a general emergency department. Referral to a specialised burn centre is recommended for:

• Burns to the face, hands, feet, genitals, or across joints, because of the risk of functional impairment and scarring
• Suspected inhalation injury, suggested by facial burns, singed nasal hair, or smoke exposure in an enclosed space
• Burns in children, due to the complexity of pain and wound management and the need to screen for non-accidental injury
• Electrical burns, including low-voltage ones, because internal damage can appear days later
• Chemical burns
• Large burns by total body surface area
• Circumferential burns encircling a limb or the chest
• Any burn expected to take longer than 14 days to heal, because of hypertrophic scarring risk

That last criterion is the one most often missed in general practice, and it is the one that determines whether a patient ends up with a manageable scar or a disabling one.

Understanding burn depth

Burn depth determines healing time, scarring risk, and whether surgery is needed. Modern classification uses descriptive terms rather than only degrees.

Depth is not always obvious in the first 48 hours, which is exactly why a burn that looks superficial on day one should still be reviewed. Reduced or absent sensation is a warning sign, not a good sign. It suggests nerve endings have been destroyed.

How burn wounds actually heal

Wound healing is not linear, and understanding the phases helps explain why scars behave the way they do.

• Inflammatory phase, days 0 to 5. Blood vessels constrict then dilate, immune cells arrive, and debris is cleared. Swelling, redness, and pain belong to this phase. Excessive or prolonged inflammation here is one of the strongest predictors of a bad scar later.
• Proliferative phase, days 4 to 21. New tissue forms. Fibroblasts lay down collagen, new blood vessels grow, and keratinocytes migrate across the wound to close it. This is where the two to three week threshold sits. If the wound closes within this window, scarring risk stays relatively low. Deeper partial thickness burns that stall here can convert into non-healing wounds, which is a different clinical problem covered on our chronic wound and skin repair page.
• Remodelling phase, week 3 to 24 months. The disorganised collagen laid down quickly during proliferation is gradually replaced by stronger, better-aligned collagen. A scar is at its most red, raised, and firm somewhere between two and six months, then slowly softens and fades. This is why the scar you have at month three is not the scar you will have at month eighteen, and why patience is genuinely part of the treatment.

Hypertrophic scars raise because collagen production outruns collagen breakdown. They stay within the original wound boundary. Keloids extend beyond it and do not regress spontaneously, and they occur more frequently in Asian, African, Middle Eastern, and Latin American skin. That makes keloidal burn scarring a realistic risk for many patients in Thailand, and it needs a more aggressive plan than a hypertrophic scar does. See our keloid treatment page for how that differs.

Severe burn treatment: what happens in hospital

Major burn care is inpatient work, and it is worth knowing the outline so the process is less frightening.

• Resuscitation. Large burns cause massive fluid shifts. Intravenous fluid resuscitation in the first 24 to 48 hours is calculated by body weight and burn surface area, and is adjusted against urine output.
• Airway management. Inhalation injury can cause airway swelling that develops over hours. Early intubation may be needed before swelling makes it difficult.
• Wound management and debridement. Dead tissue is removed, because it feeds infection and blocks healing.
• Grafting. Full thickness burns and many deep partial thickness burns will not close on their own. Split-thickness skin grafts, and in some cases dermal substitutes, are used to achieve closure. Faster closure means less scarring.
• Infection control and nutrition. Burn patients are hypermetabolic and immunosuppressed. Nutritional support and infection surveillance are central, not peripheral.
• Early rehabilitation. Splinting, positioning, and range of movement work start early, because contractures form fast and are far easier to prevent than to release.

Treatment for burn scars

Once the skin is intact and stable, scar management begins. The evidence base here is clearer than most patients expect.

Silicone

Silicone gel or silicone gel sheeting is universally considered the first-line prophylactic and treatment option for hypertrophic scars and keloids, and international clinical recommendations support it as first-line therapy for widespread burn hypertrophic scars once the epithelium is intact and stable. It works by hydrating and occluding the scar rather than by any drug effect.

Practical points: apply to closed skin only, never to open wounds, use it for at least 12 hours a day, and continue for months rather than weeks. Gel formulations tend to have better adherence than sheeting because they are easier to use in visible areas and in a humid climate.

Pressure therapy

Custom pressure garments applied to healing burn scars are a long-standing part of burn rehabilitation. The critical point for timing is that pressure prevents scars but does not treat them once they are established. Referral should be initiated promptly at the first sign of hypertrophic scarring, or if the wound misses expected healing milestones.

Intralesional corticosteroid

For raised, firm, itchy, or painful scars, injected corticosteroid remains a mainstay alongside silicone. Concentrations used on the face and neck are usually limited to reduce the risk of skin atrophy. It is a therapeutic agent rather than a preventive one.

Fractional laser

Positive data supports the use of fractional lasers for burn scar treatment, and ablative fractional lasers offer the advantage of fewer sessions than non-ablative options. A single-centre retrospective review of 110 ablative fractional CO2 sessions across 40 adult and paediatric patients with hypertrophic burn scars found no infectious complications, no skin complications, and no unplanned admissions within six weeks of any treatment, concluding that the approach was safe and well tolerated.

Laser is used to improve pliability, reduce thickness, relieve itch, and improve range of movement across joints. It is a functional treatment as much as a cosmetic one.

Massage, moisturising, and itch control

Scar massage, consistent moisturising, and itch management are unglamorous and genuinely useful. Itch after re-epithelialisation is very common and can be treated with moisturisers, cool cloths, massage, and oatmeal preparations, with oral antihistamines as first-line for moderate to severe itch. Scratching prolongs inflammation and worsens the scar, so controlling itch is scar treatment, not just comfort.

Sun protection

Newly healed skin exposed to direct sunlight can develop permanent hyperpigmentation. Sunscreen with SPF of at least 50 should be used, and direct sun avoided, for up to two years after the burn. In Thailand this is a serious commitment and it needs to be said plainly at discharge, not buried in an information sheet.

Scar management timeline

Warning signs during recovery

Return for review promptly if you notice:

• Increasing pain, redness spreading beyond the wound, pus, odour, or fever
• A wound that has not closed within two to three weeks
• A scar that is becoming raised, red, and firm
• Tightness that limits movement of a joint
• Numbness or shooting nerve pain, which is more common after full thickness burns
• A wound that closed and then broke down again

Contractures across joints are far easier to prevent with early therapy than to correct with surgery later.

How burn care works at Vega Dermatology & Wound Care Unit

We want to be precise about scope, because getting this wrong costs people tissue.

We are not an emergency burn service. Large burns, burns to the face, hands, feet, genitals or major joints, suspected inhalation injury, electrical and chemical burns, and any deep partial thickness or full thickness burn need a hospital burn unit first. Call 1669 or go directly. We coordinate with those teams rather than replacing them.

What we do handle falls into two phases.

• Phase 1, burn wound healing. Smaller outpatient burns, and patients discharged from a burn unit who still have open areas, fragile grafts, or wounds that have stalled. Standard care here is wound cleansing, debridement of devitalised tissue, topical antimicrobials, appropriate moisture-balance dressings, and monitoring for infection or conversion to a deeper injury. For selected stalled or complex burns we add regenerative protocols, including growth factor media intended to support angiogenesis and granulation. These sit on top of standard care rather than in place of it.
• Phase 2, treatment for burn scars and contractures. This is where most of our burn work happens, and where timing matters more than technology:

Preventive measures start as soon as the wound has closed and any grafts are stable. Laser and injections come later, once the skin is robust and infection risk is low. Complex or long-standing cases may also involve our scar and tissue remodeling service.

Why your last treatment may have disappointed you

A very common story in our clinic sounds like this. A patient books a course of laser, completes it, sees maybe 20 to 30% improvement, and concludes that acne scars simply cannot be fixed.

Usually the problem was not the laser. It was that the laser was asked to treat a scar type it was never going to solve on its own.

Deep ice pick scars extend into the deep dermis through a narrow opening. Fractional resurfacing treats a column of tissue but cannot reach the base of a scar that goes deeper than the device penetrates. Rolling scars are held down by fibrous bands tethering the skin to underlying tissue. No amount of surface resurfacing will release a tether. It has to be cut.

Matching procedure to anatomy is the whole discipline. Everything else is detail.

First, work out what you are actually looking at

Atrophic scars (depressed, roughly 80 to 90% of acne scarring)

• Ice pick scars. Narrow, deep, V-shaped. Look like a puncture from a fine needle. Often on the cheeks. Under 2mm wide but reach deep into the dermis.
• Boxcar scars. Round or oval with sharply defined vertical walls, like a small crater. Shallow or deep. Commonly on cheeks and temples.
• Rolling scars. Wide, shallow, with soft sloping edges that give the skin an undulating appearance. Caused by fibrous tethering below the surface. Often most visible in raking side light.

Raised scars

• Hypertrophic scars. Raised, firm, staying within the boundary of the original lesion. More common on the chest, shoulders, and jawline.
• Keloids. Raised scars that grow beyond the original lesion boundary and do not regress on their own. Higher risk in Asian, African, Middle Eastern, and Latin American skin, which makes them a common presentation in Thailand. They behave differently enough from hypertrophic scars to need their own approach, covered on our keloid treatment page.

Not scars

• Post-inflammatory erythema (PIE). Flat pink or red marks. Dilated capillaries left after inflammation. Common in lighter skin.
• Post-inflammatory hyperpigmentation (PIH). Flat brown or grey-brown marks. Excess melanin left after inflammation. Very common in Thai and other Asian skin.

Both are flat. Run a fingertip over them. If the surface is smooth and level, it is discolouration and not a scar, and it should not be treated with an aggressive resurfacing device. Many patients spend a great deal of money resurfacing marks that would have faded with sun protection and a topical.

Treatment matched to scar type

What the evidence says about combining treatments

The clearest message across the research is that combinations work better than monotherapy.

A retrospective analysis of 413 patients found that fractional CO2 laser combined with subcision achieved a 92.09% overall efficacy rate compared with 77.78% for fractional CO2 laser alone. A randomised study of 40 patients found that subcision combined with either fractional CO2 laser or cross-linked hyaluronic acid filler produced significantly greater improvement than subcision alone, measured on Goodman and Baron grading. Systematic review evidence similarly reports that combination therapy generally achieves superior clinical improvement over single-modality treatment, particularly for scar texture, depth reduction, and patient-reported satisfaction.

Case series using triple combinations of TCA CROSS, subcision, and microneedling, each targeting a different mechanism, report consistently high patient satisfaction.

The reason is mechanical. Subcision releases tethering. TCA CROSS reaches into narrow deep scars that lasers cannot. Fractional resurfacing rebuilds collagen across the surface. Fillers or biostimulators restore volume. They address different problems, so stacking them compounds the result rather than duplicating it.

Where regenerative therapy fits

A newer layer sits alongside these. Regenerative and cell-based approaches, which many patients search for as stem cell therapy for acne scars Bangkok clinics offer, aim to improve collagen production, elasticity, and overall tissue quality rather than to reshape the scar mechanically.

Our position on this is deliberately conservative. Early studies and clinical experience suggest a benefit in atrophic scarring, particularly when used inside a broader programme, but long-term data is still developing. We treat it as a promising adjunct that supports tissue quality after the structural work has been done, not as a stand-alone cure and not as a substitute for subcision or resurfacing. Any clinic presenting it as a single-session fix for deep scarring is overselling it.

The Asian skin factor, which many articles skip

This is the part that matters most for patients in Bangkok.

Most Thai patients fall into Fitzpatrick skin types III to V. Melanocytes in these skin types are more reactive, so heat and inflammation are more likely to trigger post-inflammatory hyperpigmentation. Fractional CO2 laser is widely regarded as an effective option for acne scar remodelling across skin types I to V, but its use in darker skin types is challenging, with PIH incidence reported as high as 100% in some case series.

That does not mean lasers are off the table for Thai skin. It means technique matters more:

• Conservative energy and density. Comparative review data shows adverse effects in 28% of patients treated with high-energy fractional CO2 settings versus 9% with low-energy protocols. More sessions at lower energy is often the better trade for pigmented skin.
• Fractional rather than fully ablative delivery. Treating microscopic columns and sparing surrounding tissue speeds healing and lowers inflammatory load.
• Non-ablative and radiofrequency microneedling options. A retrospective review of 115 sessions using a 1,550nm non-ablative fractional laser in Fitzpatrick IV to VI patients recorded PIH in only 4% of sessions. RF microneedling delivers energy into the dermis through insulated needles while largely sparing the epidermis, which reduces pigment risk.
• Pre-conditioning and post-treatment protocols. A study of pre- and post-treatment chemical peeling around fractional CO2 resurfacing reported a median PIH severity score of zero in the treated group, versus meaningful pigmentation in controls.
• Strict sun protection. Non-negotiable in Bangkok. Daily broad-spectrum SPF 50, reapplied, plus physical shade for the weeks after each session.

If a clinic proposes the same settings for you that they would use on a Northern European patient, that is a reason to ask more questions.

The order of operations

Step 1: Control active acne. Resurfacing skin that is still breaking out produces new scars. Acne should be stable before scar treatment begins. If you are on or recently finished isotretinoin, your doctor will discuss timing for procedures.

Step 2: Map the scars. A proper consultation should identify which types you have and in what proportion, ideally with photography under angled lighting that reveals depth. Most patients have a mixture, which is why one procedure rarely does everything.

Step 3: Sequence the plan. Deep and structural work first, in many cases. Subcision and TCA CROSS address architecture. Resurfacing then smooths what remains. Volume correction comes last, once you can see what is left.

Step 4: Space sessions properly. Four to eight weeks between sessions gives collagen remodelling time to happen. Collagen continues to reorganise for three to six months after your last session, which means your final result is not the one you see at the two-week review.

Step 5: Maintain. Sun protection, a retinoid if appropriate, and ongoing acne control protect the result.

What to ask a Bangkok clinic before booking

1. Which scar types do I have, and in what proportion?
2. Which procedure are you using for each type, and why that one?
3. Is the procedure performed by a doctor, and what is their specialty training?
4. What settings will you use for my skin type, and what is your protocol for preventing PIH?
5. What is the full course cost, and what does it include if I need an extra session?
6. Can I see before and after photographs of patients with my scar type and my skin tone?
7. What happens if I develop pigmentation afterwards, and is that follow-up included?

The photograph question is the most revealing. Results on Fitzpatrick II skin tell you very little about what will happen to Fitzpatrick IV skin.

Recovery, honestly

• Fractional laser: Redness and a sandpaper texture for three to seven days. Swelling for the first 48 hours. Fine bronzing and flaking as the treated columns shed. Makeup usually possible from day five to seven.
• TCA CROSS: Small dark crusts at each treated point, resembling scattered dots. These last five to seven days and must not be picked. Visible and difficult to hide, so plan around social commitments.
• Subcision: Bruising and swelling for seven to fourteen days, sometimes significant. Small lumps can occur as healing tissue forms and usually settle.
• RF microneedling: Redness for one to three days, sometimes grid-pattern marks for 24 to 48 hours.

Across all of them, the two rules that most affect your outcome are: do not pick, and do not expose the area to direct sun.

How acne scar treatment is planned at Vega Derma, Bangkok

Because most patients arrive with a mixture of scar types, we start with scar mapping rather than with a device.

At consultation we photograph the face under angled lighting and map which scars are rolling, boxcar, ice pick, hypertrophic, or keloidal, and separately identify which marks are actually PIE or PIH and therefore should not be resurfaced at all. That map is what the protocol is built from.

A typical acne scar treatment in Bangkok plan with us combines two to four of the following, sequenced across sessions:

Two things we do differently, and both are specific to treating Thai and Southeast Asian skin. Device settings, post-procedure care, and session spacing are adjusted for your Fitzpatrick type rather than run at default parameters, because aggressive protocols on pigmented skin cause more harm than benefit. And progress is tracked with standardised photography at every visit, so improvement is documented rather than remembered.

What a hair follicle actually is

A hair follicle is not a passive tube. It is a small organ, and it is the only organ in the human body that regenerates itself in cycles for your entire life.

Each follicle moves through three phases:

• Anagen, the growth phase, which for scalp hair lasts roughly two to seven years. The length of anagen determines how long your hair can grow.
• Catagen, a short regression phase where the lower part of the follicle breaks down.
• Telogen, a resting phase, after which the old hair is released and a new cycle begins.

During each cycle, the upper third of the follicle stays intact while the lower two thirds is dismantled and rebuilt. That rebuilding is driven by two cell populations working together: hair follicle stem cells in the bulge, and dermal papilla cells at the base of the follicle. When those two remain healthy and in communication, the follicle can be reactivated even after a long period of suppression.

This is the entire premise of follicle repair therapy.

Miniaturisation is not the same as loss

In androgenetic alopecia, follicles do not disappear overnight. They shrink.

Dihydrotestosterone (DHT) binds to androgen receptors in the dermal papilla and triggers release of inhibitory signals. The follicle responds by shortening its anagen phase, sitting more superficially in the skin, and reducing the size of its dermal papilla. Over successive cycles, a terminal hair becomes progressively finer and shorter until it resembles fine down.

Two details from this process matter enormously to patients.

• First, the stem cell is usually still there. Current research describes the miniaturisation spectrum as a state where the hair follicle stem cell is physically retained but its output to progenitor cells is restricted, with these niches sitting in reversible or semi-reversible pathological dormancy. Dormant is a very different word from dead.
• Second, fibrosis builds up around the follicle over time. DHT signalling in the dermal papilla stimulates surrounding fibroblasts to deposit excess type I collagen, producing perifollicular fibrosis. Researchers note that the severity of this fibrosis may correlate with clinical stubbornness and poor treatment response. In practical terms, the longer a follicle sits in a stiffening, inflamed environment, the harder it becomes to wake it up.

That is the honest argument for treating early. Not urgency marketing. Tissue biology.

If you are weighing up which treatments to start with, our companion guide to non-surgical hair restoration sorts the available options by strength of evidence.

What can be repaired, and what cannot

The distinction that runs through this table is visible under a trichoscope in minutes. Present follicular openings and fine vellus hairs mean living follicles. Smooth, shiny skin with absent openings means the follicle is gone.

Anyone selling you follicle repair without looking for this is selling you something they have not verified you can benefit from.

The 90-day question, answered properly

Search results are full of pages promising follicle restoration in 90 days. Here is what 90 days actually corresponds to.

Ninety days is approximately one telogen-to-anagen transition plus early anagen. It is the window in which a treatment can plausibly:

• Push resting follicles into a new growth phase
• Stop or slow ongoing shedding
• Produce fine, short, often unpigmented new hairs that you can see on close inspection
• Improve scalp inflammation, if inflammation was a factor

What 90 days cannot do:

• Convert those fine new hairs into full terminal hairs. That takes many more months of continued anagen.
• Reverse established perifollicular fibrosis
• Restore density in an area with no remaining follicular openings
• Produce a before-and-after photograph that fairly represents your final result

If you accept the first list and reject the second, 90 days is a genuinely useful checkpoint. It is a progress review, not a finish line.

How follicle repair therapy works, mechanism by mechanism

Effective protocols do not rely on a single lever. They stack interventions that address different parts of the problem.

• Reducing androgen signalling. 5-alpha-reductase inhibitors such as finasteride reduce DHT, removing the upstream driver of miniaturisation and, over time, of perifollicular fibrosis. This is the mechanism with the strongest evidence base in men.
• Extending anagen and improving follicular blood supply. Minoxidil, topical or low-dose oral, prolongs the growth phase and improves perifollicular circulation. It is the only pharmacological treatment approved by the US FDA for pattern hair loss in both sexes.
• Supplying growth factor signalling. Platelet-rich plasma delivers a concentrated mix of platelet-derived growth factors into the scalp. There is a plausible biological basis for this: platelet-derived growth factor signalling has been shown to be crucial for hair follicle dermal stem cell function, with PDGF-BB enhancing proliferation and improving the inductive capacity of those cells in experimental models. Clinical trial results are broadly positive, though protocols vary widely between clinics.
• Increasing cellular energy availability. Low-level laser therapy targets cytochrome c oxidase in the mitochondria of bulge stem cells, increasing ATP production. Meta-analysis of FDA-cleared devices found a significant density gain versus sham.
• Controlled micro-injury. Microneedling triggers a wound-healing signalling cascade and improves delivery of topical agents. Evidence is strongest for microneedling used alongside minoxidil or PRP.
• Restoring the signalling environment itself. This is the mechanism that the first four do not directly address. A follicle sitting in a degraded niche has lost access to the morphogens and mitogenic proteins it needs to hold anagen, and no vasodilator or DHT inhibitor replaces those. This is the rationale behind hair follicle regeneration stem cell therapy, which in our clinic takes the form of a secretome-led protocol rather than a live-cell injection. It delivers a concentrated set of signalling molecules to the follicular environment, with the aim of re-initiating the transcriptional programmes behind robust keratinisation.
• It is worth being straight about where this sits on the evidence ladder. The mechanistic rationale is well supported. The clinical trial base is still developing, and protocols vary widely between providers. We position it as a regenerative adjunct within a wider plan, not as a replacement for treatments with FDA approval behind them.
• Removing the obstacle. If seborrhoeic dermatitis, folliculitis, iron deficiency, thyroid dysfunction, or a medication is contributing, no amount of growth stimulation will outrun it. Correcting these is often the highest-yield part of a plan and the part most often skipped. It is also why our stem cell therapy for hair loss programme treats scalp preparation as a distinct step before any signalling is delivered, since scaling, hyperkeratosis, and heavy sebum physically block delivery to the follicular bulb.

A realistic recovery timeline

The reason standardised photography matters so much is that a 10 to 15% density change is invisible in a bathroom mirror and obvious in a fixed-position photograph. Ask your clinic to take baseline images at day one. If they do not, take your own with a consistent part line, consistent lighting, and the same distance every time.

How to tell if your follicles are still alive

Some of this you can assess yourself, though none of it replaces an examination.

Encouraging signs:

• Fine, short, colourless hairs visible when you part the hair and look closely
• Hairs of noticeably different thicknesses in the same area, which indicates miniaturisation in progress rather than completed loss
• Scalp skin that looks normal, with visible pore openings
• Gradual thinning over years rather than sudden patches

Concerning signs that need prompt assessment:

• Smooth, shiny patches with no visible pore openings
• Redness, scaling, pustules, or tenderness around the hairline
• Burning or itching that precedes hair loss
• A hairline that has moved backwards with loss of the fine baby hairs entirely
• Hair loss over a previous burn, surgical site, or injury

The second list points toward scarring processes. In those conditions, the treatment window is defined by how much follicle you still have, and every month of delay costs you some of it.

Where scalp wound care and hair medicine overlap

Most hair clinics treat pattern hair loss. Fewer are set up to assess scalp scarring, burn-related alopecia, or chronic wounds on the scalp, and these need a different skill set: understanding tissue perfusion, scar remodelling, and when to intervene surgically.

If your hair loss followed a burn, a graft, radiotherapy, an infection, or a surgical scar, the question is not which growth serum to use. It is whether the tissue can support hair at all, and what can be done to improve the quality of that tissue first. That assessment belongs with a unit that handles wound care and dermatology together.

How we assess follicle viability at Vega Derma

The whole article above comes down to one question, and it takes about fifteen minutes to answer properly.

At Vega Derma clinic, every hair consultation begins with high-magnification trichoscopy and digital follicular mapping. We are looking for three things: whether follicular openings are still present, what your terminal-to-vellus hair ratio looks like across defined scalp zones, and whether there is perifollicular inflammation or early scarring in the pattern.

Those findings sort you into one of three groups, and the group determines everything that follows:

• Viable, miniaturised follicles. Regenerative and medical therapy is worth doing. Depending on the picture, that may mean stem cell therapy for hair loss with scalp preparation, hair follicle regeneration stem cell therapy as a standalone or transplant adjunct, or a medical backbone with procedural support.
• Follicles lost, tissue healthy. The conversation moves to hair transplantation.
• Follicles lost, tissue scarred. Scar and tissue remodeling comes first, and we are honest about whether grafting into that area is realistic.

We re-image at every follow-up against the same baseline, so you can see whether density is genuinely changing rather than relying on how it looked in this morning’s mirror. Our doctors will tell you at consultation if we think the answer is that no treatment is worth your money.

What “hair regrowth therapy” actually means

The phrase gets used loosely, so it is worth being precise.

Hair restoration therapy covers everything a clinic can do to increase the amount of visible hair on your scalp. That splits into two very different categories.

• Surgical restoration moves follicles. A hair transplant relocates follicular units from an area that is genetically resistant to hair loss, usually the back and sides, into an area that has thinned. It redistributes what you already have.
• Non-surgical hair restoration does not move anything. It tries to change the biological environment around follicles that are still present but underperforming, so they produce thicker, longer, more pigmented hair again.

That distinction matters more than any brand name or device, because it determines whether you are even a candidate. Non-surgical hair regrowth treatment only has something to work with when living follicles remain in the thinning area. Once a follicle has been destroyed and replaced by fibrous tissue, no serum, injection, or laser cap is bringing it back.

If you want the biology behind that in more depth, including how to tell whether your own follicles are still viable, we cover it separately in our guide to follicle repair therapy.

Before any treatment: get the diagnosis right

This is the step patients most often skip, and it is the step that wastes the most time and money.

Several conditions produce thinning hair, and they respond to entirely different things:

• Androgenetic alopecia (pattern hair loss) is progressive miniaturisation driven by androgen sensitivity in genetically predisposed follicles. It affects roughly half of men by age 50, with comparable rates reported in Asian populations.
• Telogen effluvium is a diffuse shed triggered by illness, surgery, childbirth, crash dieting, iron deficiency, or severe stress, typically two to three months after the trigger. It usually resolves once the trigger is corrected.
• Thyroid disease, iron deficiency, and certain medications can each drive shedding that no topical will fix while the underlying cause remains.
• Cicatricial (scarring) alopecia, including lichen planopilaris and frontal fibrosing alopecia, destroys the follicle permanently. Here, the priority is stopping active inflammation, not stimulating growth.
• Traction alopecia from tight styling is reversible early and permanent late.

A proper assessment should include a history, a scalp and hair examination, trichoscopy (magnified imaging of the scalp surface and follicular openings), and where indicated, blood work. A trichoscope tells your doctor whether follicular openings are still present, whether hair shaft diameters are varying (a hallmark of miniaturisation), and whether there is inflammation or scarring. Those findings decide the treatment plan.

If a clinic quotes you a package before it has looked at your scalp under magnification, that is a commercial process, not a medical one.

What the evidence actually supports

It helps to sort options into tiers rather than treating them as an equal menu.

Tier 1: Proven first-line therapy

• Topical minoxidil. Minoxidil remains the first-line therapy in most clinical scenarios because of its safety profile and established efficacy, and randomised trials show 5% formulations consistently increase hair counts. Results vary between individuals, partly because minoxidil is a prodrug that must be converted by follicular sulfotransferase enzymes, and enzyme activity differs from person to person. That is one reason two people on identical products get different outcomes.
• Oral finasteride (men). A 5-alpha-reductase inhibitor that reduces conversion of testosterone to dihydrotestosterone (DHT), the androgen that drives miniaturisation. Current evidence indicates finasteride is safe, though sexual side effects are reported in a minority of users and should be discussed openly before starting. It is not used in women of childbearing potential due to teratogenicity.
• Low-dose oral minoxidil (LDOM). An off-label but increasingly mainstream option for patients who respond poorly to topical therapy or cannot tolerate it. A recent international expert consensus went as far as considering oral minoxidil an optimal first-line therapy for both men and women. Hypertrichosis (unwanted hair growth elsewhere) is the most common side effect, and cardiovascular events are uncommon at low doses. This requires medical supervision and is not a self-prescribe treatment.

Tier 2: Supported adjuncts

• Low-level laser therapy (LLLT). Red light devices that appear to work by stimulating mitochondrial activity in follicular stem cells. A systematic review and meta-analysis of FDA-cleared home-use devices found a significant increase of 19.8 hairs per cm² in the treated group versus a decrease of 7.6 hairs per cm² in the sham group. Useful as an add-on, not as a standalone rescue for advanced loss.
• Platelet-rich plasma (PRP). Your own blood is centrifuged to concentrate platelets and their growth factors, then injected into the scalp. In a systematic review of clinical trials in androgenetic alopecia, 84% of studies reported a positive effect. The caveat is real and worth stating: preparation protocols, platelet concentrations, and injection schedules vary widely between clinics, which makes results harder to predict and harder to compare.
• Microneedling. Controlled micro-injury that appears to improve topical absorption and stimulate growth factor signalling. Most of the useful evidence is for microneedling combined with minoxidil or PRP rather than alone.

Tier 3: Regenerative and signalling-based approaches

This is the category most patients are actually searching for when they type “stem cell therapy for hair loss” into Google, and it is also the category with the widest gap between marketing and evidence. It is worth understanding what sits underneath the label, because several very different things get sold under the same three words.

• Live-cell injection means culturing and injecting actual cells. This is the most heavily regulated end of the field, the least standardised, and the one with the least published clinical data in pattern hair loss.
• Autologous micrografting takes a small sample of your own tissue and processes it into a cell suspension for reinjection.
• Secretome and conditioned media approaches do not inject cells at all. They deliver the signalling molecules that regenerative cells produce, which is a meaningfully different proposition in terms of both regulation and risk profile.
• Isolated exosomes are a further refinement of that idea.

The distinction matters clinically. There is a plausible biological rationale for signalling-based approaches, and platelet-derived growth factor signalling in particular has been shown in experimental models to be crucial for hair follicle dermal stem cell function. What does not yet exist is the volume of large randomised trial data that sits behind minoxidil and finasteride.

Our own hair follicle stem cell therapy in Thailand protocol, which we call Follicular Signaling Enhancement, sits in the secretome category rather than the live-cell one. It delivers a concentrated collection of bio-active signalling molecules to the follicular environment under physician supervision, with progress tracked by trichoscopy and digital follicular mapping rather than by impression. Our broader stem cell therapy for hair loss programme pairs that signalling with scalp environment preparation, because signalling molecules cannot reach the follicular bulb through scaling, heavy sebum, or untreated seborrhoeic dermatitis.

We describe these as regenerative adjuncts, and we think any clinic offering them owes you the same clarity: tell you which of the four categories above you are actually buying, explain that the long-term data is still developing, and never price an emerging therapy as though it carried the evidence base of an approved drug.

Treatment comparison at a glance

Why combinations beat single treatments

Pattern hair loss has more than one mechanism behind it. Androgen signalling shrinks the follicle. Blood supply and growth factor availability influence how well the follicle can support a growing hair. Perifollicular fibrosis, a low-grade scarring around the follicle, gradually stiffens the environment the follicle sits in.

Treating one mechanism while ignoring the others limits what you can achieve. The clinical data reflects this. In a meta-analysis of seven randomised controlled trials, topical minoxidil-finasteride combination therapy produced clinically meaningful improvements over minoxidil alone across hair density, hair diameter, and global photographic assessment. Reviews of PRP similarly report better outcomes when it is combined with minoxidil, microneedling, or laser therapy rather than used alone.

This is also why a credible plan is layered: a medical backbone that runs continuously, plus procedural adjuncts on a schedule, plus correction of any nutritional or hormonal contributor found on testing.

A realistic timeline

Patients quit good treatments early because nobody told them what normal looks like.

• Weeks 2 to 8. You may shed more than usual after starting minoxidil. This happens because the drug pushes resting follicles into a new growth phase, and the old hair has to be released first. It is uncomfortable and it is expected.
• Months 3 to 4. Shedding settles. You may notice fine, short, colourless hairs at the hairline or part. Those are new anagen hairs, and they are the first honest sign of response.
• Month 6. The first fair assessment point. Standardised photography under the same lighting and the same part line is the only reliable way to judge this, because daily mirror checks are useless for detecting a 10% density change.
• Months 9 to 12. Peak visible benefit for most non-surgical protocols.
• Beyond 12 months. Maintenance. Pattern hair loss is progressive. Stopping treatment means returning, over the following six to twelve months, to the trajectory you would have been on without it. This is the single most important thing to understand before you start.

When non-surgical therapy is not the right answer

An honest clinic will tell you when to stop spending on regrowth and consider something else:

• Large areas of completely smooth scalp with no visible follicular openings under trichoscopy
• Long-standing Norwood 5 or above with no miniaturised hairs remaining in the bald zone
• Established scarring alopecia, where treatment shifts to controlling inflammation
• Alopecia from burn injury or trauma, where the follicular unit and surrounding tissue have been destroyed and the discussion is about tissue quality and reconstruction rather than stimulation

In these cases, medical therapy may still have a role in protecting the hair you have while hair transplantation or reconstructive options are considered for the areas that are already lost. Where hair loss sits over a burn, graft, or old surgical scar, the tissue itself usually needs assessing first, which is work that belongs with a unit handling scar and tissue remodeling alongside hair.

What to ask before you commit

1. What is my specific diagnosis, and what did you see on trichoscopy?
2. Which parts of my plan are FDA-approved, which are supported adjuncts, and which are emerging?
3. What happens if I stop after a year?
4. How will we measure whether this is working, and on what date?
5. What are the side effects, and what is the plan if I get them?
6. Who performs the procedures, and what are their credentials?

How non-surgical hair restoration works at Vega

Our hair programme in Bangkok is built around one principle: find out what is still viable before treating anything.

Every plan starts with a medical assessment and high-magnification trichoscopy, because follicular density, terminal-to-vellus hair ratio, and signs of perifollicular inflammation are what decide whether regrowth is realistic in a given zone. From there, treatment usually falls into one of three routes, or a combination:

• Stem cell therapy for hair loss, our Hair & Scalp Regeneration programme, which prepares the scalp environment first and then delivers bio-active secretome signalling to address microcirculation, chronic micro-inflammation, and follicular dormancy. Visible changes in density and shaft thickness typically appear from three to six months.
• Hair follicle stem cell therapy in Thailand, our Follicular Signaling Enhancement protocol, used either as a standalone option for early to moderate thinning or as a peri-operative adjunct to support graft survival.
• Hair transplantation where density has already gone and redistribution is the only way to restore coverage.

Progress is documented with the same trichoscopy imaging at every visit, plus digital follicular mapping and scalp biomarker grading, so improvement is measured against a fixed baseline rather than estimated. You can review our medical team and see documented outcomes in our case studies.

We will also tell you when we do not think treatment is worth your money. That conversation happens at consultation, before any plan is quoted.

The treatment of hair loss works best when it is matched to a confirmed diagnosis rather than guessed at. For androgenetic alopecia (pattern hair loss), the strongest evidence sits with topical minoxidil and oral finasteride, with low-level laser therapy, microneedling, and platelet-rich plasma (PRP) as supported add-ons. For telogen effluvium, the fix is usually correcting the underlying trigger, not applying a product. Regenerative options such as secretome and exosome-based scalp therapy are promising but still investigational, and should only be considered under physician supervision. Most treatments need 4 to 6 months before results are fair to judge.

What Hair Loss Actually Is, Medically Speaking

Losing hair is normal. Losing density is not.

Every follicle on your scalp runs its own independent cycle, and at any given moment roughly 85 percent of your hairs are in the active growth phase (anagen) while about 15 percent are resting (telogen), a ratio documented in the clinical literature on hair cycling. A follicle typically grows hair for around four years, then rests for about four months before shedding and starting again.

That means shedding 50 to 100 hairs a day is simply the system working. The problem starts when one of two things happens:

1. Too many follicles enter the resting phase at once. You shed heavily and suddenly, but the follicles themselves are intact. This is telogen effluvium.
2. Follicles shrink over successive cycles. Each new hair comes back finer, shorter, and lighter than the last, until it stops being cosmetically visible at all. This is miniaturisation, and it is the defining process of androgenetic alopecia.

The distinction matters enormously, because the first is usually reversible on its own and the second is progressive without intervention. This is also why so many people waste twelve months on the wrong product. They are treating shedding when they have miniaturisation, or the reverse.

Shedding Versus Thinning: A Two-Question Self-Check

• Is your part line widening, or is your hairline receding? That pattern points toward androgenetic alopecia.
• Did the shedding start suddenly, roughly two to three months after an illness, a birth, a crash diet, or a period of high stress? That points toward telogen effluvium.

Neither replaces a clinical assessment, but it tells you what kind of appointment to book.

The Main Types of Hair Loss

Androgenetic Alopecia (Pattern Hair Loss)

The most common cause of hair loss worldwide, driven by a genetic sensitivity to dihydrotestosterone (DHT), a potent androgen that progressively shortens the growth phase and shrinks the follicle.

It is often assumed to be less common in Asian populations. That assumption is out of date. A randomised study of 1,124 men in Bangkok found cosmetically significant male pattern baldness (Norwood III to VII) in 38.5 percent of participants, rising steadily with age and approaching rates reported in European populations. Broader Asian consensus estimates put pattern hair loss prevalence at 41 to 73 percent across the region.

In women it presents differently: diffuse thinning across the crown with the frontal hairline usually preserved, classified on the Ludwig scale. The BASP classification is now widely used across Asia because it captures hairline shapes more common in Asian patients than the older Norwood-Hamilton system does.

Telogen Effluvium

Diffuse shedding from all over the scalp, typically starting two to three months after a trigger. Documented triggers include acute febrile illness, major surgery, severe trauma, postpartum hormonal shifts, hypothyroidism, crash dieting, low protein intake, and iron deficiency.

The reassuring part: the follicles are alive. Acute telogen effluvium is self-limiting, and once the causative factor is identified and corrected, hair growth returns without further treatment. Correcting low iron, zinc, or vitamin D restores growth where those deficiencies were the driver.

The frustrating part: it takes months, and anxiety about the shedding can itself prolong the cycle.

Alopecia Areata

An autoimmune condition producing sharply defined round patches of loss, sometimes progressing to the full scalp or body. It requires a different treatment pathway entirely, involving immunomodulation rather than growth stimulation. JAK inhibitors (baricitinib, approved by the US FDA for severe adult alopecia areata in 2022, and ritlecitinib in 2023) have changed the outlook for severe cases.

Traction Alopecia

Mechanical loss from sustained tension: tight ponytails, buns, braids, extensions. Early on it is fully reversible. Left long enough, the follicles scar and it is not. This is one of the few types of hair loss where behaviour change alone is genuinely curative if caught early.

Scarring (Cicatricial) Alopecia

Inflammatory conditions such as lichen planopilaris and frontal fibrosing alopecia that destroy the follicle and replace it with fibrous tissue. This is the one category where speed genuinely matters, because lost follicles cannot be recovered. Any hair loss accompanied by burning, itching, tenderness, or visible scalp redness warrants an urgent dermatology appointment rather than a shopping trip.

Comparison at a Glance

Why the Scalp Itself Is Part of the Treatment

Most people think about hair loss at the level of the hair. Clinically, the more useful frame is that the follicle is a small organ embedded in living tissue, and that tissue can be healthy or unhealthy.

Three scalp-level factors influence how well any treatment for hair loss performs.

Perifollicular Micro-Inflammation

Histological studies of balding scalp consistently show lymphocyte infiltration, activated T cells, and mast cell degranulation around the follicle. This persistent microinflammatory environment is closely tied to the miniaturisation process itself.

The clinically important detail: this inflammation is usually invisible. Pattern hair loss rarely presents with pain, itching, or redness, which is exactly why it goes unaddressed in self-directed treatment.

Sebaceous Change and Seborrhoeic Dermatitis

Follicular miniaturisation is often accompanied by sebaceous gland proliferation, which increases surface oil and creates a more favourable environment for pro-inflammatory microorganisms. Seborrhoeic dermatitis is the most commonly co-occurring condition in patients with androgenetic alopecia, and in one clinic series it was present in 42 percent of assessed patients.

Research on the scalp microbiome supports the link, with Malassezia restricta appearing more abundantly on scalps affected by androgenetic alopecia and also implicated in seborrhoeic dermatitis. The two conditions appear to aggravate one another.

This is the practical argument for treating the scalp environment before or alongside the follicle, and it is why ketoconazole shampoo appears in so many clinical protocols as an adjunct rather than an afterthought.

Microcirculation

The follicle is one of the most metabolically demanding structures in the body during its growth phase. Impaired local blood supply limits the oxygen and nutrient delivery that sustains anagen. This is one of the proposed mechanisms behind both minoxidil (a vasodilator by origin) and microneedling, which triggers a controlled wound-healing and angiogenic response.

If you want the detail on how scalp environment work is sequenced ahead of follicular treatment, our clinical team covers it in our approach to stem cell therapy for hair loss.

How Hair Loss Should Be Properly Diagnosed

A good assessment takes twenty minutes and saves you a year.

1. History and Pattern Classification

When it started, how fast, family history, medications, recent illness, dietary changes, and for women, menstrual and hormonal history. The pattern is then graded using Norwood-Hamilton (men), Ludwig (women), or BASP (widely preferred in Asian practice).

2. Trichoscopy

Magnified imaging of the scalp surface and follicular openings. This is where a clinician sees what you cannot see in a mirror: hair shaft diameter variability (the hallmark of miniaturisation), follicular density per square centimetre, yellow dots, perifollicular scaling, and whether follicular openings are still present, which is the key differentiator between scarring and non-scarring loss.

It is also the only honest way to measure progress later. Photographs alone flatter or punish you depending on lighting.

3. Blood Work Worth Doing

Not everyone needs a full panel, but where diffuse shedding is present the evidence supports checking:

• Serum ferritin (iron deficiency without anaemia is a recognised contributor to telogen effluvium)
• Thyroid function (both hypothyroidism and hyperthyroidism affect hair cycling)
• Vitamin D and zinc
• Androgen profile in women where there are signs of hyperandrogenism

One practical warning that catches people out: high-dose biotin supplements can interfere with immunoassay-based laboratory tests, including thyroid panels, producing falsely abnormal results. Tell your clinician what you are taking.

4. Scalp Biopsy

Reserved for suspected scarring alopecia or cases where the clinical picture is ambiguous. It is not routine, but where it is indicated it is decisive.

Treatment of Hair Loss: The Evidence-Based Options

Below, treatments are grouped by how much high-quality evidence supports them. Regulatory approval status is stated plainly, because that distinction gets blurred constantly in hair loss marketing.

Topical Minoxidil

Status: Approved by the US FDA for pattern hair loss in men and women.

The most widely used treatment for hair loss globally. It extends the growth phase and increases follicle size. Available as 2 and 5 percent solutions and foams.

What to expect: An initial increase in shedding during the first four to eight weeks is common and expected as follicles synchronise into a new cycle. It is the most frequent reason people quit early, and quitting early is why so many people conclude it “did not work”.

The catch: Benefits reverse when you stop.

Oral Finasteride

Status: Approved by the US FDA for male pattern hair loss since 1997.

A type II 5-alpha reductase inhibitor that reduces scalp and serum DHT by approximately 64 to 68 percent at 1 mg per day. For men with androgenetic alopecia it is the single most effective pharmacological option available.

The trade-offs: Reported adverse effects include reduced libido and erectile dysfunction. These require a genuine, unhurried conversation with a prescribing physician rather than a footnote. Finasteride is contraindicated in women who are or may become pregnant, and trial data found it ineffective in postmenopausal women with androgenetic alopecia.

Combination Therapy

Here the evidence has firmed up recently. A 2025 systematic review and meta-analysis of seven randomised controlled trials comparing a topical minoxidil-finasteride combination against minoxidil alone found clinically meaningful improvements in hair density, hair diameter, and global photographic assessment, all exceeding minimum clinically important thresholds, with moderate certainty of evidence.

A separate 2025 network meta-analysis ranked minoxidil-based combinations and found that in women, microneedling combined with minoxidil ranked most effective among seven combination approaches.

The practical takeaway: single-agent treatment is rarely the ceiling.

Low-Dose Oral Minoxidil

Status: Off-label, prescription only.

Used increasingly where topical minoxidil is poorly tolerated or inconvenient, with a growing evidence base including a comprehensive 2023 review and expert consensus statements. It carries systemic considerations including fluid retention, unwanted body hair growth, and cardiovascular effects, so it is a physician-supervised option only. Notably, one of the significant open-label studies of oral minoxidil in male androgenetic alopecia was conducted by Thai investigators at Chulalongkorn University.

Anti-Androgens for Women

Spironolactone and cyproterone acetate are used in women, particularly those with hyperandrogenic profiles, who tend to respond better. The evidence base in female pattern hair loss is thinner than for men’s treatments, and side effect profiles require monitoring.

Ketoconazole Shampoo and Scalp Care

Often dismissed as “just anti-dandruff shampoo”. Given the documented overlap between seborrhoeic dermatitis and androgenetic alopecia, and ketoconazole’s anti-inflammatory and mild anti-androgenic activity at the scalp, it has a legitimate adjunctive role, particularly in patients with visible scaling or oiliness.

Low-Level Laser Therapy (Photobiomodulation)

Status: Multiple home-use devices hold US FDA 510(k) clearance. The first, the HairMax LaserComb, was cleared for male pattern hair loss in 2007 and for female pattern hair loss in 2011.

A systematic review of double-blinded randomised controlled trials concluded it is a promising non-invasive option that is safe for home self-administration. A real-world study of 1,383 patients using an FDA-cleared laser helmet reported overall clinical effectiveness near 80 percent, with median use of roughly 38 to 40 weeks before assessment.

Important nuance: FDA clearance confirms safety and substantial equivalence to an existing device. It is not the same as approval based on demonstrated efficacy, and it does not guarantee a result for any individual. Evidence in telogen effluvium specifically is weak, so this is a pattern hair loss tool.

Microneedling

Controlled micro-injury to the scalp that stimulates wound-healing signalling and improves absorption of topical agents. It performs best in combination rather than alone, and in the 2025 network meta-analysis it was the top-ranked partner for minoxidil in women. Depth, frequency, and sterile technique matter, which is a real argument for clinical rather than at-home use.

Platelet-Rich Plasma (PRP)

Status: Autologous, widely offered, not a licensed drug.

The evidence is genuinely positive but genuinely messy, and it is worth stating both halves.

In favour: A meta-analysis of nine RCTs found PRP significantly increased hair density versus placebo at three and six months, with no serious adverse events reported. Another meta-analysis of six RCTs (343 participants) found PRP combined with minoxidil significantly outperformed either alone, with a pooled increase in hair density and diameter, and higher patient satisfaction.

Against, or at least cautioning: A 2024 systematic review of 13 RCTs found a mean difference of 27.55 hairs per cm² in favour of PRP, but described the studies as highly heterogeneous, of low quality, and showing evident publication bias. Hair diameter results were not consistently significant across analyses.

Honest summary: PRP appears to increase hair density in appropriately selected patients. Protocols are not standardised, results vary between clinics, and anyone presenting it as settled science is overselling it.

Regenerative and Cell-Signalling Therapies

Status: investigational. This is the most important sentence in this article.

Stem cell-derived conditioned media, secretome preparations, and exosomes have shown the ability in laboratory and early clinical work to activate Wnt/beta-catenin signalling, enhance angiogenesis, modulate inflammation, and support dermal papilla cell survival, with improvements in hair density and shaft thickness and favourable early safety signals.

That is a real and interesting mechanistic story. It is also incomplete. A 2025 scoping review of regenerative therapies for androgenetic alopecia concluded plainly that stem cell and exosome therapies face regulatory challenges and lack robust safety data, and that clinical application has outpaced the gathering of high-quality evidence. No stem cell product or processing method is approved by the FDA or other major authorities for androgenetic alopecia, and in April 2024 the FDA issued a consumer alert clarifying that marketed stem cell and exosome treatments for hair loss remain unapproved investigational biologics.

Manufacturing adds a further variable: exosome preparation faces documented challenges around yield, purity, batch-to-batch variability, and the absence of standardised administration protocols.

What this means for you as a patient: these therapies should be discussed as an emerging, physician-supervised option with realistic framing, appropriate consent, and objective progress tracking, not as a guaranteed alternative to established treatment. Any clinic that presents them as proven is telling you something about the clinic. If you want to understand how signalling-based approaches are structured and monitored clinically, our team explains the protocol under hair follicle stem cell therapy Thailand.

Hair Transplantation

Status: Established surgical intervention.

Follicular unit extraction (FUE) and direct hair implantation (DHI) relocate DHT-resistant follicles from the donor area into thinning zones. Transplanted follicles are permanent in their new location.

Two things people underestimate. First, transplantation redistributes existing hair, it does not create new follicles, so donor supply sets the ceiling on what is achievable. Second, it does not stop the underlying condition, which is why most surgeons insist on ongoing medical therapy afterwards to protect the native hair around the grafts. Details of the surgical pathway are covered under hair regrowth therapy.

Treatment Comparison

Which Treatment Is Right for You?

Use this as a conversation starter with a clinician, not a substitute for one.

• Early thinning, no visible bald area. This is the best position to be in and the most commonly wasted opportunity. Preventing loss is far easier than reversing it. Topical minoxidil, plus finasteride for men, plus scalp environment correction if there is any scaling or oiliness.
• Moderate loss with a visible pattern. Combination therapy becomes the sensible default given the 2025 meta-analytic evidence. Consider adding microneedling or laser therapy, and discuss PRP with realistic expectations attached.
• Advanced loss with established bald zones. Follicles in fully bald areas are generally beyond medical rescue. This is the transplantation conversation, alongside medical therapy to protect what remains.
• Female pattern thinning. Diagnosis first, always, because iron and thyroid status change the plan. Minoxidil is the anchor. Anti-androgens where clinically appropriate. Microneedling combined with minoxidil has the strongest comparative ranking in the recent network meta-analysis for women.
• Sudden diffuse shedding after illness, birth, or major stress. Do not start an aggressive treatment protocol. Get ferritin, thyroid, vitamin D, and zinc checked, correct what is low, and give it time. Most acute telogen effluvium resolves within three to six months once the trigger is addressed.
• Any redness, burning, itching, or loss of follicular openings. Stop researching and book a dermatology appointment. Scarring alopecia is a clock, not a project.

Realistic Timelines

Hair biology is slow, and every credible clinician will tell you the same thing.

Anything promising visible transformation in four weeks is selling you something.

Hair Loss Treatment in Thailand: How to Choose a Clinic

Bangkok has become a genuine hub for hair restoration, which means both excellent clinics and opportunistic ones. The difference is usually visible in the first consultation.

Signals of a serious clinic:

• Trichoscopic assessment before any treatment is proposed
• A named diagnosis, not a package name
• Baseline measurements you can be shown again at follow-up
• Willingness to say a treatment is investigational when it is
• A physician, not a salesperson, explaining the plan
• An itemised quotation with no time-limited pressure

Red flags:

• A price quoted before an examination
• Guaranteed results, in writing or verbally
• Stem cell or exosome therapy described as approved or proven
• No discussion of maintenance
• Before-and-after photos with inconsistent lighting, angles, or hair length

What You Can Do at Home

Modest, genuine, and worth doing. Just not a substitute for treatment.

• Protein and iron intake. Hair is keratin. Chronically low protein and low ferritin both show up in the shedding literature.
• Reduce mechanical tension. No tight ponytails, buns, or extensions worn continuously. Traction alopecia is one of the few fully preventable forms of hair loss.
• Treat scalp flaking properly rather than masking it, given the documented overlap between seborrhoeic dermatitis and pattern hair loss.
• Be sceptical of supplements. Correcting a diagnosed deficiency helps. Supplementing above requirement generally does not, and high-dose biotin can distort your lab results.
• Manage sleep and stress. Not because stress alone causes pattern baldness, but because it is a well-documented trigger for telogen effluvium.

Common Myths

• “Wearing hats causes baldness.” No. Tension does, hats generally do not.
• “If you shed hair when you start minoxidil, it is damaging your hair.” No. Synchronised cycling is an expected early phase.
• “Pattern hair loss comes from your mother’s father.” Oversimplified. Androgenetic alopecia is polygenic, with contributions from both sides of the family.
• “Natural means safe and effective.” Neither follows automatically. Finasteride is synthetic and heavily studied. Many botanical hair products are neither studied nor standardised.
• “You can regrow hair on a fully bald scalp without surgery.” Where follicular openings are gone, medical therapy has nothing to act on.

The Bottom Line

The treatment of hair loss is not complicated by a lack of options. It is complicated by an abundance of options applied without a diagnosis.

Get the diagnosis. Establish a baseline you can measure against. Start with what the evidence supports, add adjuncts where they are indicated, and treat emerging regenerative therapies as exactly what they currently are: promising, supervised, and not yet proven. Then give it six months before you decide anything.

Hair responds to consistency far more reliably than it responds to intensity.